|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial 显示文摘 | HANNON R A CLACK G RIMMER M | 2010 | J Bone Miner Res2010，25，3： | 1 |
| 2 | Service increment for teaching(SIFT) :a review of its origins, development and current role in supporting undergraduate medical education in England and Wales 显示文摘 | Clack GB Bevan G Eddleston AL | 1999 | Med Educ1999，33，5： | 1 |
| 3 | Limit Cycle Oscillations in Pulse-Modulated Systems 显示文摘 | Clack R N Franklin G F | 2009 | Spacecraft2009，6，7： | 1 |
| 4 | Long-term effects of anast rozole on bone mineral density:7-year results from the ATAC trial显示文摘 | Eastell R Adams J Clack G | 2011 | Ann Oncol2011，22，4： | 1 |
| 5 | Long-term evaluation of prosthetic mitral valves in sheep显示文摘 | Irwin E Lang G Clack K | 1993 | J Invest Surg1993，6，2： | 1 |
| 6 | Effects of the Sre ki- nase inhibitor saracatinib (AZD0530) on bone turnover in health men: A randomized, double-blinded, placebo-con- trolled, multiple ascending dose phase I trial显示文摘 | Hannon RA Clack G Rimmer M | 2010 | J Bone Min- er Res2010，25，： | 1 |
| 7 | Effects of Srckinase inhibition by saracatinib (AZD0530) on bone turnoverin advanced malignancy in a phase I study 显示文摘 | Hannon R A Finkelman R D Clack G | 2012 | Bone2012，50，4： | 1 |
| 8 | A prototypical process for creating evi- dentiary standards for biomarkers and diagnostics 显示文摘 | Altar CA Amakye D Bounos D Bloom J Clack G Dean R | 2008 | Clin Pharmacol Ther2008，83，2： | 1 |
| 9 | Design and testing of a contra-rotating tidal current turbine显示文摘 | CLACK J A CONNOR G GRANT A D | 2007 | Journal of Power and Enery2007，221，2： | 1 |
| 10 | Effects of the Src Kinase Inhibitor Saracatinib (AZD0530) on Bone Turnover in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending- Dose Phase 1 Trial 显示文摘 | Hannon RA Clack G Rimmer M | 2010 | J Bone Miner Res2010，25，3： | 1 |
| 11 | Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial显示文摘 | Hannon RA Clack G Rimmer M | 2010 | J Bone Miner Res2010，25，： | 1 |
| 12 | 查看详情显示文摘 | Lockton J.A Smethurst D Macpherson M Tootell R Marshall A.L Clack G Gallagher N.J | | 0，，： | 1 |
| 13 | Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial 显示文摘 | Hannon R A Clack G Rimmer M | 2010 | J Bone Miner Res2010，25，3： | 1 |
| 14 | Eft ects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending- dose phase I trial显示文摘 | Hannon RA Clack G Rimmer M | 2010 | J Bone Miner Res2010，25，： | 1 |
| 15 | Effects of the Src kinase inhibitor saracatinib (AZD0530)on bone turnover in healthy men : a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial显示文摘 | Hannon RA Clack G Rimmer M | 2010 | J Bone Miner Res2010，25，3： | 1 |
| 16 | Prognostic factor and treatment decisions in axillary-node-negitive breast cancer 显示文摘 | McGuire W L Clack G M | 1992 | N Engl J Med1992，326，26： | 1 |
| 17 | Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride,a dual 5alpha-reductase inhibitor显示文摘 | Clack R V Hemann D J Cunningham G R | 2004 | J Clin Endocrinol Metab2004，89，5： | 1 |
| 18 | Eff ects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men:a randomized,double-blind,placebo-controlled,multiple-ascending-dose phase I trial显示文摘 | Hannon RA Clack G Rimmer M | | 0，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员